World soccer's governing body FIFA will test its semi-automated offside technology at the Arab Cup 2021 which begins in Qatar on Tuesday, with Chief Refereeing Officer Pierluigi Collina saying the competition represented its most important trial so far.

The technology is based on limb tracking and provides the Video Assistant Referee (VAR) with information before the on-field official takes a final call.

"We'll have a camera setup installed under the roof of each stadium," FIFA's Football Technology and Innovation Director Johannes Holzmueller said in a statement on Monday.

"The limb-tracking data extracted from the video will be sent to the operations rooms and the calculated offside line and detected kick-point is provided to the replay operator in almost real time.

"The replay operator then has the opportunity to show it immediately to the VAR. At the FIFA Arab Cup the assistant VAR at a dedicated offside station can immediately validate and confirm the information."
FIFA's Chief of Global Football Development Arsene Wenger said in April that he hoped the organisation would be ready to implement the technology at next year's World Cup in Qatar.

In March, former Netherlands forward Marco van Basten called on football's lawmakers to consider scrapping the offside rule, saying that the sport would be better off without it.

The game has seen several contentious offside calls since the introduction of the VAR, with growing concern about the time taken and the precision with which offsides are judged.

"Technology is very important and useful in both the pre-match preparation and the decision-making process during matches," Collina said.

"In an offside incident, the decision is made after having analysed not only the players' position but also their involvement in the move.

"Technology – today or tomorrow – can draw a line but the assessment of an interference with play or with an opponent remains in the referee's hands."

SOURCE: REUTERS

Islamabad: Pakistan has offered to host the extraordinary session of the Council of Foreign Ministers of the Organization of Islamic Cooperation (OIC) to discuss the latest situation in Afghanistan.

In a video message, the Foreign Minister Shah Mahmood Qureshi said Pakistan fully endorses this initiative of Saudi Arabia, the current OIC summit chair.

He said Pakistan also offers to host this meeting in Islamabad on the 17th of next month.

Shah Mahmood Qureshi said we are confident that the OIC member states will endorse this offer.

He said Afghanistan is currently facing a serious humanitarian situation as millions of Afghans including women and children are confronted with an uncertain future due to a shortage of food, medicine and other essential living supplies.

The Foreign Minister said the advent of winter has exacerbated the humanitarian crisis.

He urged the OIC to step up to alleviate the humanitarian needs of the Afghan people, provide immediate and sustained support to them, and continue to remain engaged with them for the wellbeing and prosperity of Afghanistan.

Bourla told CNBC that his company on Friday began testing the current vaccine against the Omicron variant, which was first reported in South Africa and reignited fears of a global wave of Covid-19 infections.

"I don't think the result will be the vaccines don't protect," Bourla said.

But the testing could show that existing shots "protect less," which means "that we need to create a new vaccine," Bourla said.

"Friday we made our first DNA template, which is the first possible inflection of the development process of a new vaccine," he said.

Bourla likened the situation to the scenario earlier this year when Pfizer and its German partner BioNTech developed a vaccine in 95 days when there were concerns the previous formula would not work against Delta, though that version ultimately was not used.

The current vaccine is "very effective" against Delta, the executive said, adding that the companies expect to be able to produce four billion vaccine doses in 2022.

On Monday, the World Health Organization warned the new Covid-19 Omicron variant poses a "very high" risk globally.

Bourla said he was also "very confident" that Pfizer's recently unveiled antiviral pill would work as a treatment for infections caused by the mutations, including Omicron.

Among newly-infected, high risk patients treated within three days of the onset of symptoms, Pfizer's pill has been shown to cut hospitalization or death by nearly 90 percent.

SOURCE: AFP/CNBC